Company Description At Bosch, we shape the future by inventing high-quality technologies and services that spark enthusiasm and enrich people’s lives. Our promise to our associates is rock-solid: we grow together, we enjoy our work, and
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Who we are At Helsing we deliver AI-based capabilities and the enabling foundation that allow machines to perceive and assist human decision-making. You will have the unique opportunity to shape AI capabilities in one of the
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description Join Us as a Site Contract Specialist – Make an Impact at the Forefront of Innovation At Thermo Fisher Scientific, you’ll discover meaningful work that makes a positive impact
We are looking to support our rapidly growing team as soon as possible: PhD Student (f/m/x) – Translational Metabolism Research Poliklinik für Endokrinologie, Diabetologie und Präventivmedizin TV-L: 38,5 h/week (100%) limited for 3 years according to
We are looking to support our rapidly growing team as soon as possible: Doctoral Researcher / PhD Candidate in Immunotherapy of Viral Infections (f/m/x) Institute of Virology - Laboratory of Experimental lmmunology TV-L: 25 h/week (64,94%)
We are looking to support our rapidly growing team starting October 1, 2026: Doctoral Researcher / PhD Candidate (f/m/x) – Proteostasis and Secretory Pathway Regulation Biochemie - Institut für Biochemie II TV-L: 25 h/week (64,94%) Fixed-term
We are looking to support our rapidly growing team as soon as possible: Scientific Data Platform Engineer (f/m/x) Biomedizinische Informatik TV-L: 38,5 h/week (100%) initially limited for 2 years with the possibility of extension according to
We are looking to support our rapidly growing team as soon as possible two: Doctoral Researchers (f/m/x) Institut für Radiochemie und Experimentelle Molekulare Bildgebung TV-L: 25 h/week (64,94%) limited for 2 years according to WissZeitVG. Following
We are looking to support our rapidly growing team as soon as possible: Postdoctoral Researcher (f/m/x) - Biomarker Discovery in Neurodegenerative and Neuropsychiatric Disorders Psychiatrie und Psychotherapie TV-L: 38,5 h/week (100%) limited for 2 years according
We are looking to support our rapidly growing team as soon as possible: Doctoral Researcher / PhD Candidate in translational viral immunity (f/m/x) Institute of Virology - Laboratory of Experimental lmmunology TV-L: 25 h/week (64,94%) limited
We are looking to support our rapidly growing team as soon as possible: Postdoctoral research position (f/m/x) in translational viral immunity Institute of Virology - Laboratory of Experimental lmmunology TV-L: 38,5 h/week (100%) limited for 3
CRA II Germany - eastern Germany (Leipzig, Halle, Berlin) Syneos Health® is a leading fully-integrated life sciences services organization built to accelerate customer success. We partner with innovators at every point across the drug development and
Who we are Helsing is a defence AI company. Our mission is to protect our democracies. We aim to achieve technological leadership, so that open societies can continue to make sovereign decisions and control their ethical
Inyova is the leading digital platform for investing with a sustainability impact. Through the Inyova platform, people can invest their money in companies that represent the causes they care about (like sustainability, gender equality, etc.) –
Focused Energy is building the future of clean energy through laser-driven inertial fusion. Backed by our $240M Series A — the largest fully secured Series A in the global fusion industry — we are scaling rapidly